Plain-English translation of NCT06283719 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can help people with advanced small cell lung cancer or neuroendocrine cancer. The study has two parts: first, researchers will test different doses to find the safest and most effective amount, and then they will test the best dose in a larger group of patients to confirm it works.
Advanced small cell lung cancer and neuroendocrine cancer are serious diseases that are difficult to treat, especially after patients have tried other therapies. This medication is being studied to see if it offers a new treatment option for people who have not had success with earlier treatments.
You likely qualify if…
You likely don't qualify if…
If you join, you will receive the medication at one of several hospitals taking part in the study. In the first part of the trial, you will be among a small group receiving a specific dose, and researchers will watch carefully for any side effects. If the dose is safe, the next group will receive a higher dose. Once the best dose is found, the second part of the trial will enroll more patients to confirm the medication works. Throughout the study, you will have regular visits for blood tests, physical exams, and imaging scans to monitor your health and how you are responding to treatment.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China